Our Mission

Imagine a future where a blood sample reveals the health of your organs and how well the organs responding to a treatment — no biopsies, no uncertainty:

• Revolutionizing patient care: Accurate, non-invasive diagnosis and truly personalized treatment.

• Advancing public health: Reduces clinical burden and accelerate treatment/drug development.

• Promoting sustainability: Cuts medical waste and reduces need for invasive procedures.

• Driving economic value: Lowers healthcare costs.

At EVGenomics, we are building that future through organ-specific EV isolation combined with ultra-sensitive RNA/protein biomarker analysis and AI-driven data interpretation. We aim to evolve this platform into a CRO service supporting biomarker discovery, while also developing an EV isolation kit to empower clients to conduct their own organ-specific EV research.